Disclosure Notice
|
|
Life Pharmacy Limited (LPL) | 3:33 pm, Friday 29 August 2008 | LPL | 0.460 |
 0 |
(+0.00%) |
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Samuel Olukayode Shosanya
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer General Manager Marketing and
Merchandising
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Life Pharmacy Trustee Company Limited (LPTCL)
Class and type of security (as required by regulation 6B or
regulation 8) Partly paid redeemable ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Beneficial owner pursuant to an Employee Share
Ownership Plan Deed between LPL, LPTCL and Samuel Olukayode Shosanya
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 25 August
2008
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 20 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Shares acquired by way of an issue of securities by LPL pursuant to an
employee share ownership plan
Consideration (as required by regulation 10) $0.55 per share (of
which $0.01 per share is paid up)
Number of securities held prior, set out by class and type (as
required by regulation 8) 12,500 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 250,000 partly paid redeemable ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 12,500 ordinary shares; 250,000 partly paid
redeemable ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Craig Robert Wilson
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Chief Financial Officer
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Life Pharmacy Trustee Company Limited (LPTCL)
Class and type of security (as required by regulation 6B or
regulation 8) Partly paid redeemable ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Beneficial owner pursuant to an Employee Share
Ownership Plan Deed between LPL, LPTCL and Craig Robert Wilson
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 25 August
2008
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 20 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Shares acquired by way of an issue of securities by LPL pursuant to an
employee share ownership plan
Consideration (as required by regulation 10) $0.55 per share (of
which $0.01 per share is paid up)
Number of securities held prior, set out by class and type (as
required by regulation 8) 12,500 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 250,000 partly paid redeemable ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 12,500 ordinary shares; 250,000 partly paid
redeemable ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Desmond Colin Flynn
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer General Manager Strategic
Business Development
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Life Pharmacy Trustee Company Limited (LPTCL)
Class and type of security (as required by regulation 6B or
regulation 8) Partly paid redeemable ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Beneficial owner pursuant to an Employee Share
Ownership Plan Deed between LPL, LPTCL and Desmond Colin Flynn
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 25 August
2008
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 20 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Shares acquired by way of an issue of securities by LPL pursuant to an
employee share ownership plan
Consideration (as required by regulation 10) $0.55 per share (of
which $0.01 per share is paid up)
Number of securities held prior, set out by class and type (as
required by regulation 8) 8,750 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 175,000 partly paid redeemable ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 8,750 ordinary shares; 175,000 partly paid
redeemable ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Janice Evelyn Jones
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer General Manager Corporate
Relations
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Life Pharmacy Trustee Company Limited (LPTCL)
Class and type of security (as required by regulation 6B or
regulation 8) Partly paid redeemable ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Beneficial owner pursuant to an Employee Share
Ownership Plan Deed between LPL, LPTCL and Janice Evelyn Jones
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 25 August
2008
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 20 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Shares acquired by way of an issue of securities by LPL pursuant to an
employee share ownership plan
Consideration (as required by regulation 10) $0.55 per share (of
which $0.01 per share is paid up)
Number of securities held prior, set out by class and type (as
required by regulation 8) 6,250 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 125,000 partly paid redeemable ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 6,250 ordinary shares; 125,000 partly paid
redeemable ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Jacqueline Ann Dabrowski
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Merchandise Manager Beauty
Brands
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Life Pharmacy Trustee Company Limited (LPTCL)
Class and type of security (as required by regulation 6B or
regulation 8) Partly paid redeemable ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Beneficial owner pursuant to an Employee Share
Ownership Plan Deed between LPL, LPTCL and Jacqueline Ann Dabrowski
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 25 August
2008
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 20 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Shares acquired by way of an issue of securities by LPL pursuant to an
employee share ownership plan
Consideration (as required by regulation 10) $0.55 per share (of
which $0.01 per share is paid up)
Number of securities held prior, set out by class and type (as
required by regulation 8) 4,000 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 80,000 partly paid redeemable ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 4,000 ordinary shares; 80,000 partly paid
redeemable ordinary shares
G Signature
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of directors' and officers' relevant interests
Section 19T, Securities Markets Act 1988
A Disclosure obligation (tick box to note which disclosure obligation
applies)
Initial disclosure (complete Parts A, B,
C, D, F, and G of this notice) ? Ongoing disclosure (complete Parts A,
B,
C, E, F, and G of this notice)
B Preliminary
Name Wai Yong Seet
Name of issuer Life Pharmacy Limited (LPL)
Name of related body corporate (if applicable) N/A
Position you hold in the issuer Merchandise Manager Health
and Personal Care
Date of this disclosure notice 25 August 2008
C Nature of relevant interest
Name of registered holder(s) of security (as required by regulation
6A(b) or regulation 7(b)) Life Pharmacy Trustee Company Limited (LPTCL)
Class and type of security (as required by regulation 6B or
regulation 8) Partly paid redeemable ordinary shares
Nature of relevant interest in security (as required by regulation
6A(a) or regulation 7(a)) Beneficial owner pursuant to an Employee Share
Ownership Plan Deed between LPL, LPTCL and Wai Yong Seet
D Date (for initial disclosure)
Date of disclosure obligation (as required by regulation 6C)
E Transaction (for ongoing disclosure)
Date of last disclosure (as required by regulation 13) 25 August
2008
Date(s) of acquisition(s) or disposal(s) (as required by regulation
9) 20 August 2008
Number of transactions (as required by regulation 12(2), if
applicable) N/A
Nature or type of transaction (as required by regulation 11(1)(a))
Shares acquired by way of an issue of securities by LPL pursuant to an
employee share ownership plan
Consideration (as required by regulation 10) $0.55 per share (of
which $0.01 per share is paid up)
Number of securities held prior, set out by class and type (as
required by regulation 8) 4,000 ordinary shares
Number of securities subject to acquisition or disposal (as required
by regulation 11(1)(b)) 80,000 partly paid redeemable ordinary shares
F Extent of relevant interest
Number of securities held now, set out by class and type (as required
by regulation 6B or regulation 8) 4,000 ordinary shares; 80,000 partly paid
redeemable ordinary shares
G Signature
Signature (as required by regulation 14)
